Back to my company list

Owkin

The AI engine Fit Assessment

Beta

Owkin effectively utilizes machine learning to discover patterns, expand therapeutics, and identify biomarkers, enhancing personalized medicine.

Blurb

Owkin is an AI precision medicine company with a vision to find the right drug for every patient.

HQ Location

New York (United States)

Founded

2016

Employees

201 - 500

Total funding raised

$304.10M

Last Funding Event

Series B, $50.00M, June 8, 2022

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Biomarker Identification

Developer of machine learning tools designed to augment medical and biological research. The company's tool integrates biomedical images, genomics, and clinical data to discover mechanisms and biomarkers associated with diseases and treatment outcomes and build models that are as interpretable as possible, enabling researchers in hospitals, universities, and pharmaceutical companies to understand why drug efficacy varies from patient to patient, enhance the drug development process and identify the best drug for the right patient to improve treatment outcomes.